← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2010Last known activity
Sep 1, 2020
Timeline
1980s
- Jan 1, 1983
King Fahad Medical City— Founded
Drugs by trial phase (15 distinct, 10 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Brain Injuries
- Brain Ischemia
- Cerebral Infarction
- Eclampsia
- Emergencies
- Glioblastoma
- Hepatitis
- Hepatitis C
- Hepatitis C, Chronic
- Infertility
- Irritable Bowel Syndrome
- Ischemia
- Nervous System Diseases
- Neurologic Manifestations
- Pre-Eclampsia
- Status Asthmaticus
- Stroke
- Trauma, Nervous System
- Vitamin D Deficiency
- Wounds and Injuries
Recent trials (23)
- NCT04386525Lead sponsorPhase 4Sep 1, 2020
- NCT04386525Reponsible party - principal investigatorPhase 4Sep 1, 2020
- NCT04347681Lead sponsorPhase 2Apr 12, 2020
- NCT04347681CollaboratorPhase 2Apr 12, 2020
- NCT04347681Overall official - principal investigatorPhase 2Apr 12, 2020
- NCT03813043Study directorN/AFeb 15, 2019
- NCT03813043Lead sponsorN/AFeb 15, 2019
- NCT03813043Reponsible party - principal investigatorN/AFeb 15, 2019
- NCT03578640Lead sponsorPhase 3Jul 1, 2018
- NCT03578640Reponsible party - principal investigatorPhase 3Jul 1, 2018
- NCT03374163Overall official - principal investigatorPhase 2Jan 1, 2015
- NCT03374163Reponsible party - principal investigatorPhase 2Jan 1, 2015
- NCT03374163Lead sponsorPhase 2Jan 1, 2015
- NCT02275663Lead sponsorPhase 2Dec 1, 2014
- NCT02275663Overall official - principal investigatorPhase 2Dec 1, 2014
Details
- Founded
- Riyadh City, SA Jan 1, 1983
- Last known activity
- Sep 1, 2020